Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities

Author: Chan Yeu Pu, MD, MS , Christine M. Lusk, MPH, Christine Neslund-Dudas, PhD, Shirish Gadgeel, MD, Ayman O. Soubani, MD, Ann G. Schwartz, MPH, PhD

Publication source: JTO Clinical and Research Reports

Country: USA

Date: August 01 2022

Summary of content: This study shows that lung cancer screening criteria should select candidates with minimal cardiopulmonary comorbidities who are fit for curative lung cancer resection.

The USPSTF 2021 qualifies an additional group of screening candidates who are healthier with better lung reserve, translating to better surgical candidacy but potentially more overdiagnosis. The PLCOm2012, with its better accuracy in selecting patients at risk of cancer, selects an older group with chronic obstructive pulmonary disease but with good lung reserve and potentially less over-diagnosis.

Link to document:

RESEARCH - The State of Global Lung Cancer Research - 2020 data now published / NEWS - global COVID-19 updates